The global Nutraceutical Gummies Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Nutritional Class (Vitamin & Minerals, Dietary Fiber, Prebiotics & Probiotics, Polyunsaturated & Fatty Acids, Antioxidants), By Functionality (Digestive Health, Immunity & Strength, Cardiovascular Health, Bone & Muscles Health), By Age Group (Pediatric, Geriatric, Adult), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drugstores, Supermarkets, Online Stores, Others)
The nutraceutical gummies market in 2024 is expanding rapidly, driven by the demand for convenient and enjoyable ways to consume dietary supplements. Nutraceutical gummies, enriched with vitamins, minerals, and other bioactive compounds, offer health benefits in a tasty and portable format. The market benefits from innovations in gummy formulation and ingredient delivery that enhance efficacy and appeal. The trend towards clean label and natural ingredients is influencing product development. Increasing consumer interest in preventive health and wellness, supported by the popularity of functional foods, is further propelling market growth.
The market report analyses the leading companies in the industry including Bayer AG, Church & Dwight Co. Inc, Life Science Nutritionals, Nature's Way, Olly Public Benefit Corp, Otsuka Holdings Co. Ltd, Pfizer Inc, Sanofi S.A., SmartyPants Vitamins, The Honest Company Inc, The Nature's Bounty Co., Zarbee's Inc, and Others.
The most prominent trend in the Nutraceutical Gummies Market is the increasing popularity of gummy supplements. Nutraceutical gummies are becoming a preferred choice among consumers for their convenience, taste, and ease of consumption, particularly among children and adults who dislike traditional pills and capsules. This trend is driven by the demand for enjoyable and palatable supplement forms.
A key driver in the Nutraceutical Gummies Market is health consciousness and the demand for functional foods. As more individuals focus on improving their overall health and wellness, there is a rising demand for nutraceutical gummies that provide essential vitamins, minerals, and other beneficial compounds. This demand supports the growth of the market as consumers seek convenient and effective ways to supplement their diet.
One significant opportunity in the Nutraceutical Gummies Market lies in innovation in nutrient profiles and flavors. Companies can develop new gummy supplements that cater to specific health needs, such as immune support, energy boosting, and digestive health, offering consumers a wide range of targeted benefits. By incorporating unique and appealing flavors, such as mixed berry, tropical fruit, and citrus, manufacturers can enhance the consumer experience and attract a broader audience, driving market growth.
In the Nutraceutical Gummies Market, Vitamin & Minerals is the largest segment. This segment's prominence is attributed to the widespread consumer demand for convenient and enjoyable ways to supplement essential nutrients. Vitamin and mineral gummies are popular due to their ease of consumption, especially among children and adults who may have difficulty taking traditional supplements. The focus on preventive health and wellness, coupled with the rising awareness of the importance of daily vitamins and minerals for overall health, drives the demand for these gummies. Additionally, the extensive range of products available and the strong market presence of established brands contribute to the dominance of vitamin and mineral gummies in the nutraceutical market.
In the Nutraceutical Gummies Market, Immunity & Strength is poised to grow the fastest over the next five years. This growth is primarily driven by increasing consumer awareness and demand for products that boost immune health and overall strength, particularly in light of recent global health challenges. Nutraceutical gummies, known for their convenience and pleasant taste, offer a user-friendly way to incorporate essential vitamins and minerals into the diet. The rise in health-consciousness, coupled with heightened concerns about maintaining immune function amidst environmental and lifestyle stressors, is fueling this segment's rapid expansion. Additionally, innovations in gummy formulations that combine traditional immune-boosting nutrients like vitamin C, zinc, and echinacea are further driving consumer interest and market growth.
In the Nutraceutical Gummies Market, the Adult age group is the largest segment. This dominance is attributable to the growing trend of health and wellness among adults, who increasingly seek convenient and enjoyable ways to meet their nutritional needs. Nutraceutical gummies have gained popularity among adults for their ease of consumption, taste appeal, and the ability to deliver essential nutrients without the need for traditional pills or capsules. Adults are increasingly incorporating gummies into their daily routines to support various health aspects, including stress management, immune function, and overall vitality. This broad acceptance and adoption across diverse health-conscious adult demographics contribute to the segment's leading market share.
In the Nutraceutical Gummies Market, Online Stores is poised to grow the fastest over the next five years. The surge in online shopping, driven by convenience and an expanded reach, has significantly impacted the market. Consumers increasingly prefer online platforms for purchasing nutraceutical gummies due to the ease of access to a wide variety of products, detailed product information, and the ability to compare prices. Additionally, the rise of e-commerce platforms offering direct-to-consumer sales, subscription models, and home delivery options further accelerates this growth. The shift towards digital shopping and the growing preference for online retail channels is driving the rapid expansion of the online stores segment.
By Nutritional Class
Vitamin & Minerals
Dietary Fiber
Prebiotics & Probiotics
Polyunsaturated & Fatty Acids
Antioxidants
By Functionality
Digestive Health
Immunity & Strength
Cardiovascular Health
Bone & Muscles Health
By Age Group
Pediatric
Geriatric
Adult
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Supermarkets
Online Stores
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Bayer AG
Church & Dwight Co. Inc
Life Science Nutritionals
Nature's Way
Olly Public Benefit Corp
Otsuka Holdings Co. Ltd
Pfizer Inc
Sanofi S.A.
SmartyPants Vitamins
The Honest Company Inc
The Nature's Bounty Co.
Zarbee's Inc
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Nutraceutical Gummies Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Nutraceutical Gummies Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Nutraceutical Gummies Market Share by Company, 2023
4.1.2. Product Offerings of Leading Nutraceutical Gummies Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Nutraceutical Gummies Market Drivers
6.2. Nutraceutical Gummies Market Challenges
6.6. Nutraceutical Gummies Market Opportunities
6.4. Nutraceutical Gummies Market Trends
Chapter 7. Global Nutraceutical Gummies Market Outlook Trends
7.1. Global Nutraceutical Gummies Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Nutraceutical Gummies Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Nutraceutical Gummies Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Nutritional Class
Vitamin & Minerals
Dietary Fiber
Prebiotics & Probiotics
Polyunsaturated & Fatty Acids
Antioxidants
By Functionality
Digestive Health
Immunity & Strength
Cardiovascular Health
Bone & Muscles Health
By Age Group
Pediatric
Geriatric
Adult
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Supermarkets
Online Stores
Others
Chapter 8. Global Nutraceutical Gummies Regional Analysis and Outlook
8.1. Global Nutraceutical Gummies Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Nutraceutical Gummies Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Nutraceutical Gummies Regional Analysis and Outlook
8.2.2. Canada Nutraceutical Gummies Regional Analysis and Outlook
8.2.3. Mexico Nutraceutical Gummies Regional Analysis and Outlook
8.3. Europe Nutraceutical Gummies Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Nutraceutical Gummies Regional Analysis and Outlook
8.3.2. France Nutraceutical Gummies Regional Analysis and Outlook
8.3.3. United Kingdom Nutraceutical Gummies Regional Analysis and Outlook
8.3.4. Spain Nutraceutical Gummies Regional Analysis and Outlook
8.3.5. Italy Nutraceutical Gummies Regional Analysis and Outlook
8.3.6. Russia Nutraceutical Gummies Regional Analysis and Outlook
8.3.7. Rest of Europe Nutraceutical Gummies Regional Analysis and Outlook
8.4. Asia Pacific Nutraceutical Gummies Revenue (USD Million) by Country (2021-2032)
8.4.1. China Nutraceutical Gummies Regional Analysis and Outlook
8.4.2. Japan Nutraceutical Gummies Regional Analysis and Outlook
8.4.3. India Nutraceutical Gummies Regional Analysis and Outlook
8.4.4. South Korea Nutraceutical Gummies Regional Analysis and Outlook
8.4.5. Australia Nutraceutical Gummies Regional Analysis and Outlook
8.4.6. South East Asia Nutraceutical Gummies Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Nutraceutical Gummies Regional Analysis and Outlook
8.5. South America Nutraceutical Gummies Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Nutraceutical Gummies Regional Analysis and Outlook
8.5.2. Argentina Nutraceutical Gummies Regional Analysis and Outlook
8.5.3. Rest of South America Nutraceutical Gummies Regional Analysis and Outlook
8.6. Middle East and Africa Nutraceutical Gummies Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Nutraceutical Gummies Regional Analysis and Outlook
8.6.2. Africa Nutraceutical Gummies Regional Analysis and Outlook
Chapter 9. North America Nutraceutical Gummies Analysis and Outlook
9.1. North America Nutraceutical Gummies Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Nutraceutical Gummies Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Nutraceutical Gummies Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Nutraceutical Gummies Revenue (USD Million) by Product (2021-2032)
By Nutritional Class
Vitamin & Minerals
Dietary Fiber
Prebiotics & Probiotics
Polyunsaturated & Fatty Acids
Antioxidants
By Functionality
Digestive Health
Immunity & Strength
Cardiovascular Health
Bone & Muscles Health
By Age Group
Pediatric
Geriatric
Adult
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Supermarkets
Online Stores
Others
Chapter 10. Europe Nutraceutical Gummies Analysis and Outlook
10.1. Europe Nutraceutical Gummies Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Nutraceutical Gummies Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Nutraceutical Gummies Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Nutraceutical Gummies Revenue (USD Million) by Product (2021-2032)
By Nutritional Class
Vitamin & Minerals
Dietary Fiber
Prebiotics & Probiotics
Polyunsaturated & Fatty Acids
Antioxidants
By Functionality
Digestive Health
Immunity & Strength
Cardiovascular Health
Bone & Muscles Health
By Age Group
Pediatric
Geriatric
Adult
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Supermarkets
Online Stores
Others
Chapter 11. Asia Pacific Nutraceutical Gummies Analysis and Outlook
11.1. Asia Pacific Nutraceutical Gummies Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Nutraceutical Gummies Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Nutraceutical Gummies Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Nutraceutical Gummies Revenue (USD Million) by Product (2021-2032)
By Nutritional Class
Vitamin & Minerals
Dietary Fiber
Prebiotics & Probiotics
Polyunsaturated & Fatty Acids
Antioxidants
By Functionality
Digestive Health
Immunity & Strength
Cardiovascular Health
Bone & Muscles Health
By Age Group
Pediatric
Geriatric
Adult
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Supermarkets
Online Stores
Others
Chapter 12. South America Nutraceutical Gummies Analysis and Outlook
12.1. South America Nutraceutical Gummies Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Nutraceutical Gummies Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Nutraceutical Gummies Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Nutraceutical Gummies Revenue (USD Million) by Product (2021-2032)
By Nutritional Class
Vitamin & Minerals
Dietary Fiber
Prebiotics & Probiotics
Polyunsaturated & Fatty Acids
Antioxidants
By Functionality
Digestive Health
Immunity & Strength
Cardiovascular Health
Bone & Muscles Health
By Age Group
Pediatric
Geriatric
Adult
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Supermarkets
Online Stores
Others
Chapter 13. Middle East and Africa Nutraceutical Gummies Analysis and Outlook
13.1. Middle East and Africa Nutraceutical Gummies Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Nutraceutical Gummies Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Nutraceutical Gummies Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Nutraceutical Gummies Revenue (USD Million) by Product (2021-2032)
By Nutritional Class
Vitamin & Minerals
Dietary Fiber
Prebiotics & Probiotics
Polyunsaturated & Fatty Acids
Antioxidants
By Functionality
Digestive Health
Immunity & Strength
Cardiovascular Health
Bone & Muscles Health
By Age Group
Pediatric
Geriatric
Adult
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Supermarkets
Online Stores
Others
Chapter 14. Nutraceutical Gummies Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
Bayer AG
Church & Dwight Co. Inc
Life Science Nutritionals
Nature's Way
Olly Public Benefit Corp
Otsuka Holdings Co. Ltd
Pfizer Inc
Sanofi S.A.
SmartyPants Vitamins
The Honest Company Inc
The Nature's Bounty Co.
Zarbee's Inc
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Nutraceutical Gummies Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Nutraceutical Gummies Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Nutraceutical Gummies Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Nutraceutical Gummies Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Nutraceutical Gummies Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Nutraceutical Gummies Market Share (%) By Regions (2021-2032)
Table 12 North America Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Table 15 South America Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Nutraceutical Gummies Revenue (USD Million) By Region (2021-2032)
Table 17 North America Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Table 18 North America Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Table 19 North America Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
Table 26 South America Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Table 27 South America Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Table 28 South America Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Nutraceutical Gummies Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Nutraceutical Gummies Market Share (%) By Regions (2023)
Figure 6. North America Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 12. France Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 12. China Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 14. India Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Nutraceutical Gummies Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Nutraceutical Gummies Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Nutraceutical Gummies Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Nutraceutical Gummies Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Nutraceutical Gummies Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Nutraceutical Gummies Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Nutraceutical Gummies Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Nutraceutical Gummies Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Nutraceutical Gummies Revenue (USD Million) By Product (2021-2032)
By Nutritional Class
Vitamin & Minerals
Dietary Fiber
Prebiotics & Probiotics
Polyunsaturated & Fatty Acids
Antioxidants
By Functionality
Digestive Health
Immunity & Strength
Cardiovascular Health
Bone & Muscles Health
By Age Group
Pediatric
Geriatric
Adult
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Drugstores
Supermarkets
Online Stores
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Nutraceutical Gummies Market Size is valued at $22.6 Billion in 2024 and is forecast to register a growth rate (CAGR) of 17.3% to reach $81 Billion by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
Bayer AG, Church & Dwight Co. Inc, Life Science Nutritionals, Nature's Way, Olly Public Benefit Corp, Otsuka Holdings Co. Ltd, Pfizer Inc, Sanofi S.A., SmartyPants Vitamins, The Honest Company Inc, The Nature's Bounty Co., Zarbee's Inc
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume